[Skip to Navigation]
April 15, 1988

The FDA's New Procedures for the Use of Investigational Drugs in Treatment

Author Affiliations

From the Food and Drug Administration, Rockville, Md.

From the Food and Drug Administration, Rockville, Md.

JAMA. 1988;259(15):2267-2270. doi:10.1001/jama.1988.03720150043034

The Food and Drug Administration has established new procedures to make promising investigational drugs available for treatment of patients with immediately life-threatening or serious diseases as early in the drug development process as possible and well before general marketing begins. The purpose of this article is to inform the medical community about these new procedures and to facilitate their implementation. Examples of immediately life-threatening and serious diseases are given and the procedures that physicians should use to obtain a drug under the new regulations are described. The treatment use of zidovudine (Retrovir), while still in the investigational phase, is described as a case study. The article also summarizes the Food and Drug Administration's new procedures under which drug sponsors can charge for investigational drugs.

(JAMA 1988;259:2267-2270)